Abstract:Pathological features of Alzheimer's disease (AD) include aggregation of amyloid beta (Aβ) and tau protein. Chemokine-like receptor 1 (CMKLR1) is a G protein-coupled receptor, expressed mainly in mononuclear cells and adipocytes. Our previous study have found that CMKLR1 also expressed in brain and is a functional receptor of Aβ. However, it remains unclear whether CMKLR1 affects cognition and tau phosphorylation. The effects of CMKLR1 in cognition and tau protein were examined in Cmklr1−/- mice receiving intracerebroventricular (ICV) injection of streptozotocin (STZ) and in APP/PS1 transgenic mice mated with Cmklr1−/- mice. Marris water maze, open field test, elevated plus maze, and rotarod test were used to detect the learning and memory, anxiety, space exploration, and motion balance ability respectively. The phosphorylation of tau protein was examined by Western Blotting (WB). The expression of CMKLR1 were determined by immunofluorescence (IF). ICV-TAU mouse model was established to verify the effect of CMKLR1 in tau seeding. CMKLR1 deficiency significantly increased the survival rate of APP/PS1+/- mice. CMKLR1 deficiency improved the cognitive ability of the mice of these two AD models, but had no effect on the anxiety of the mice. In addition, CMKLR1 deficiency alleviated the abnormal hyperphosphorylation of tau in the brains of these AD model mice. Inhibition of CMKLR1 also attenuated hyperphosphorylation of tau protein induced by high glucose treatment in SH-SY5Y cells. CMKLR1 deficiency inhibited hyperphosphorylation of tau protein in hippocampus and cortex of ICV-TAU mice. These results indicate that CMKLR1 deletion can ameliorate cognitive impairment in AD. CMKLR1 mediates the phosphorylation level of tau protein and the transmission of phosphorylate tau by tau seeding. Therefore, inhibition of CMKLR1 may be useful in AD prevention and treatment.

Role of monocarboxylate transporter 4 in Alzheimer disease

Age-related changes in brain metabolites and cognitive function in APP/PS1 transgenic mice.

The Effect of Chronic Cerebral Hypoperfusion on Amyloid-β Metabolism in a Transgenic Mouse Model of Alzheimer's Disease (PS1V97L).

Lactate Deficit in an Alzheimer Disease Mouse Model: The Relationship With Neuronal Damage

Inhibition of the mitochondrial pyruvate carrier in astrocytes reduces amyloid and tau accumulation in the 3xTgAD mouse model of Alzheimer's disease

Alzheimer’s Disease Enhanced Tonic Inhibition is Correlated With Upregulated Astrocyte GABA Transporter-3/4 in a Knock-In APP Mouse Model

Tβ4 and PDTC displayed recovery on the glial and neuronal alterations in an early Alzheimer’s disease model

Proteomic profiles of the early mitochondrial changes in APP/PS1 and ApoE4 transgenic mice models of Alzheimer disease.

Supplementation of Medium-Chain Triglycerides Combined with Docosahexaenoic Acid Inhibits Amyloid Beta Protein Deposition by Improving Brain Glucose Metabolism in APP/PS1 Mice

P4‐129: CHEMOKINE LIKE RECEPTOR 1 DEFICIENCY IMPROVES COGNITION AND ATTENUATES TAU HYPERPHOSPHORYLATION IN MOUSE MODELS OF ALZHEIMER'S DISEASE

Increased Expression of SLC25A18 is Associated with Alzheimer’s Disease and is Involved in Aβ42-induced Mitochondrial Dysfunction and Apoptosis in Neuronal Cells

Cell-autonomous Effects of APOE4 in Restricting Microglial Response in Brain Homeostasis and Alzheimer’s Disease

Cell-autonomous effects of APOE4 in restricting microglial response in brain homeostasis and Alzheimer's disease

APOE4 impairs the microglial response in Alzheimer's disease by inducing TGF-mediated checkpoints

The Effect of Acetyl-L-carnitine and R-α-lipoic Acid Treatment in ApoE4 Mouse As a Model of Human Alzheimer's Disease

Temporal Characterization of the Amyloidogenic APPswe/PS1dE9;hAPOE4 Mouse Model of Alzheimer's Disease

Upregulation of MIF As a Defense Mechanism and a Biomarker of Alzheimer’s Disease

Studies on APP Metabolism Related to Age-Associated Mitochondrial Dysfunction in APP/PS1 Transgenic Mice.

APOE4 impairs the microglial response in Alzheimer's disease by inducing TGFβ-mediated checkpoints

Discrepancy of synaptic and microtubular protein phosphorylation in the hippocampus of APP/PS1 and MAPT×P301S transgenic mice at the early stage of Alzheimer's disease

Locomotor Hyperactivity in the Early-Stage Alzheimer's Disease-like Pathology of APP/PS1 Mice: Associated with Impaired Polarization of Astrocyte Aquaporin 4